Innovation Spinoff

Official Collaborated with:

Scientists in lab coats using MGI lab equipment and computers in a modern research facility.

Our Research

We translate discoveries into innovative solutions and therapies.

From Bench to Business

Our spin-offs take EPSC technology from the bench directly to market.

Building an EPSC Spin-off Ecosystem

We connect EPSC technology with industry partners, investors, and innovators to turn breakthroughs into products and services that change lives.

Our spin-offs are active across genome editing, antiviral drug discovery, immuno-oncology, skincare, and scalable cell manufacturing. This is what’s possible when science meets translation.

Our Innovative Spinoffs

is a biotechnology company specializing in science-driven skincare and cosmeceutical innovation through its proprietary ingredient, STEM ELIXIR.

pioneers the development of GMP-grade mesenchymal stem cells (MSCs) derived from EPSCs, offering a sustainable and scalable alternative to umbilical cord-based MSCs.

is at the forefront of next-generation immuno-oncology, pioneering CAR-macrophage (CAR-M) therapies specifically designed to target solid tumors. Our primary focus is on liver cancer (HCC) patients who are resistant to current treatment.

accelerates antiviral innovation through its proprietary placenta-like stem cell platform, enabling rapid and accurate discovery of novel antiviral candidates and development of effective antiviral drugs and health products.

is revolutionizing stem cell research by advancing EPSC technologies. Our expertise includes the derivation of superior EPSC lines, manufacturing premium EPSC culture media.

specializes in cutting-edge genome editing for mice models. We collaborate with academic institutions and pharmaceutical companies to deliver genetically engineered mice and cell lines, accelerating translational research and drug discovery.

Our Spin-offs

Estelle Biovita

Develops skincare powered by proprietary bioactive ingredients. Their flagship STEM ELIXIR line bridges biotechnology and beauty to deliver science-backed formulations.

Lucio Biotech

Produces GMP-grade mesenchymal stem cells (MSCs) derived from EPSCs. Their scalable, sustainable platform offers a consistent alternative to umbilical cord-based MSCs for regenerative medicine.

Synhealer

Develops Antibody-CAR-Macrophage (AB-CAR-M) therapies with dual targeting against solid tumors in patients resistant to current treatments. Their lead program focuses on hepatocellular carcinoma (HCC), a high-unmet-need indication.

Trophy Life Tech Co.

Leverages a proprietary placenta-like stem cell platform to accelerate the discovery of next-generation antiviral drugs and health solutions.

Expo Biotech

Advances stem cell research with superior cell lines and premium culture media. Their tools give researchers and biotech developers a stronger foundation for stem cell applications.

Genome Technology

Specializes in precision genome editing for mouse models, delivering custom genetically engineered mice and cell lines.

MabGenix

Develops fully human antibodies through two complementary platforms: a Transgenic Mouse platform that generates high-affinity antibodies by replacing murine immune genes with human sequences, and an AI platform that rapidly screens and prioritizes top candidates.

Our Spin-offs

Estelle Biovita

Develops skincare powered by proprietary bioactive ingredients. Their flagship STEM ELIXIR line bridges biotechnology and beauty to deliver science-backed formulations.

Lucio Biotech

Produces GMP-grade mesenchymal stem cells (MSCs) derived from EPSCs. Their scalable, sustainable platform offers a consistent alternative to umbilical cord-based MSCs for regenerative medicine.

Synhealer

Trophy Life Tech Co.

Leverages a proprietary placenta-like stem cell platform to accelerate the discovery of next-generation antiviral drugs and health solutions.

Expo Biotech

Advances stem cell research with superior cell lines and premium culture media. Their tools give researchers and biotech developers a stronger foundation for stem cell applications.

Genome Technology

Specializes in precision genome editing for mouse models, delivering custom genetically engineered mice and cell lines.

MabGenix

Develops skincare powered by proprietary bioactive ingredients. Their flagship STEM ELIXIR line bridges biotechnology and beauty to deliver science-backed formulations.

Estelle Biovita

Produces GMP-grade mesenchymal stem cells (MSCs) derived from EPSCs. Their scalable, sustainable platform offers a consistent alternative to umbilical cord-based MSCs for regenerative medicine.

Lucio Biotech

Synhealer

Leverages a proprietary placenta-like stem cell platform to accelerate the discovery of next-generation antiviral drugs and health solutions.

Trophy Life Tech Co.

Advances stem cell research with superior cell lines and premium culture media. Their tools give researchers and biotech developers a stronger foundation for stem cell applications.

(Expo Biotech has rebranded to GNG Biotech )

GNG Biotech

View Website

Specializes in precision genome editing for mouse models, delivering custom genetically engineered mice and cell lines.

Genome Technology

MabGenix

Single domain antibodies (VHH) hold great promise as versatile modular building blocks for novel therapeutic modalities and multi-specific biologics. Our startup is set to establish a transgenic mouse platform for in vivo discovery of therapeutic single domain antibodies (VHH).

NexusAb

Move Science Forward

We are driving future growth through an expanding portfolio of innovative spin-off companies, strengthening our global network and collaborative impact.